Clinical Study
Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
Table 4
Time course of biochemical paramters in cardiac transplant recipients on low-dose EVL (LD) or high-dose EVL (RD).
| Parameter | | | | value | LD ; RD | LD ; RD | LD ; RD |
| Creatinine (mg/dL) | | | | | LD group | | | | 0.030 | RD group | | | | 0.725 | BUN (mg/dL) | | | | | LD group | | | | 0.003 | RD group | | | | 0.420 | Triglycerides (mg/dL) | | | | | LD group | | | | 0.006 | RD group | | | | 0.063 | Total cholesterol (mg/dL) | | | | | LD group | | | | 0.029 | RD group | | | | 0.013 | HDL-cholesterol (mg/dL) | | | | | LD group | | | | 0.639 | RD group | | | | <0.001 | LDL-cholesterol (mg/dL) | | | | | LD group | | | | 0.815 | RD group | | | | 0.611 | White blood cells (106/L) | | | | | LD group | | | | 0.202 | RD group | | | | 0.268 | Red blood cells (1012/L) | | | | | LD group | | | | <0.001 | RD group | | | | 0.076 | Platelets (109/L) | | | | | LD group | | | | 0.819 | RD group | | | | 0.467 |
|
|